Apheris

Life sciences data networks for AI

Founded 2019 Germany

Berlin, Germany 64 employees Series A Total: $35.00M AI, Analytics +2

General Information

Company Name Apheris

Founded Year 2019

Location

Berlin, Germany

Founders / Decision Makers

Employees 64

Industries AI, Analytics, Cyber Security +1

Funding Stage Series A

Business Model B2B, Platform, SaaS

Revenue Model Subscription, Usage Based, Service Fee

Offices as of Oct 2026

‏Berlin ‏، ‏DE‏, ‏Berlin ‏، ‏DE‏

Social

BounceWatch is an independent company data service, not affiliated with Apheris. To contact Apheris, visit apheris.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Apheris compare?

A PDF of Apheris and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Apheris soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

LinkedIn Growth Oct 24, 2026

LinkedIn followers decreased by 86% over 29 days (5,514 → 758).

Growth Metrics Oct 21, 2026

Apheris reports that More than 20 of the largest pharma companies work with them, highlighting their significant customer base.

New Partnership Oct 20, 2026

Apheris announced a partnership with T-Systems International (Deutsche Telekom) to make clinical and pharma data usable for AI on sovereign, German-operated infrastructure.

Event Participation Oct 19, 2026

Apheris's CEO, Robin Roehm, is participating as a speaker at NVIDIA’s Biopharma Summit in Berlin on Thursday.

Feature Release Oct 13, 2026

Apheris's team, led by Principal Engineer Nicolas Gautier, implemented a solution that reduced federated training "compute overhead" waiting time from 99% to 20%.

Get alerts when Apheris shows new signals

About Apheris

Apheris, established in 2019 and headquartered in Germany, is at the forefront of revolutionizing drug discovery through AI-driven solutions. The company's slogan, "Life sciences data networks for AI," succinctly encapsulates its mission to enhance pharmaceutical research via sophisticated data management and collaboration.

Apheris distinguishes itself by providing enterprise-grade AI applications that empower pharma companies to undertake drug discovery securely within their proprietary IT infrastructure. By ensuring all data remains local, Apheris enables companies to maintain comprehensive control over IP-sensitive assets.

The recent Series A investment of $20.80M in January 2025 underscores investor confidence. Esteemed investors include LocalGlobe & Latitude, Octopus Ventures, Heal Capital, Dig Ventures, OTB Ventures, and eCAPITAL. Apheris operates within the key industries of AI, Analytics, Cyber Security, and Machine Learning, signaling a robust foundation for disruptive growth in healthcare technology.

Business keywords: Life Sciences, AI Applications, Drug Discovery, Pharmaceuticals, Federated Learning, Data Sovereignty, Privacy and Security, Data Collaboration, Deep Learning, Biomedical Data, NLP, Data Harmonization, Data Ecosystem, Data Governance, Secure Data Sharing

Services & Products

AI Model Development

Federated Data Collaboration

Secure Inference and Data Privacy

Model Benchmarking and Customization

Protein-Complex Prediction Models

Target Customers

Pharmaceutical Companies Drug Discovery Teams R&D Departments AI and Machine Learning Engineers in Biopharma Collaborative Pharma Networks

Funding Rounds & Investors (6)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$20.80M	6	LocalGlobe & Latitude, Octopus Ventures +4	01 Jan 2025
Early VC	€8.70M	8	LocalGlobe & Latitude, Octopus Ventures +6	01 Nov 2022
Seed	$3.00M	8	LocalGlobe & Latitude, Another.vc +6	01 Oct 2021
Seed	Undisclosed	1	Intel Ignite	01 Apr 2021
Seed	€2.50M	9	LocalGlobe & Latitude, Another.vc +7	01 Aug 2020
Seed	Undisclosed	1	Another.vc	01 Jun 2019

Latest News

View All

Apheris and Ginkgo unite four pharma giants to train AI on 10,000 antibodies

Dealroom Sep 29, 2026

Ginkgo Datapoints, Apheris Announce Founding Members of Antibody Developability Consortium

Genetic Engineering and Biotechnology News Sep 29, 2026

Ginkgo Bioworks: Apheris gründet Antikörper-Konsortium

AD HOC NEWS Sep 29, 2026

Apheris Alternatives & Competitors

View All Alternatives

Apheris vs

Lifebit United States

We built the Federated Trusted Research Environment for the world's most sensitive health data.

Series B

67 employees

AI, Biotechnology

Compare Apheris vs Lifebit

Apheris vs

Bitfount United Kingdom

Federated AI for life sciences and clinical research. Built for secure AI collaborations.

Series A

20 employees

AI, Analytics

Compare Apheris vs Bitfount

Apheris vs

OWKIN United States

From token to patient impact

396 employees

AI, Biotechnology

Also compare with:

Lynx.MD

Netrias

Partex.AI Technology View all alternatives

FAQ About Apheris

Life sciences data networks for AI

Apheris was founded in 2019.

Apheris is headquartered in Berlin, Germany. As of Oct 2026, it also has offices in ‏Berlin ‏، ‏DE‏, ‏Berlin ‏، ‏DE‏.

Apheris operates in AI, Analytics, Cyber Security and Machine Learning. Its work centres on Life Sciences, AI Applications, Drug Discovery and Pharmaceuticals. Its customers include Pharmaceutical Companies, Drug Discovery Teams and R&D Departments.

Apheris has a B2B, Platform and SaaS business model. Its revenue comes from Subscription, Usage Based and Service Fee.

Apheris has approximately 64 employees.

Apheris has completed 6 funding rounds, raising a total of $35.00M. The latest funding stage is Series A.

Apheris offers: AI Model Development, Federated Data Collaboration, Secure Inference and Data Privacy, Model Benchmarking and Customization, Protein-Complex Prediction Models.

Top alternatives and competitors to Apheris include Lifebit, Bitfount, OWKIN, Elucidata, BenevolentAI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Apheris and Lifebit are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Apheris, https://bouncewatch.com/company/apheris-ai, updated 12 October 2026. When citing, please name BounceWatch and link this page.

Apheris

General Information

Discover More

What changed at Apheris recently?

About Apheris

Services & Products

Target Customers

Funding Rounds & Investors (6)

Latest News

Apheris Alternatives & Competitors

FAQ About Apheris